Prof. Czechowicz is a translationally oriented-physician scientist at the Stanford University School of Medicine in the Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine. She is also a member of the Stanford Center for Definitive and Curative Medicine and the Stanford Institute of Stem Cell Biology and Regenerative Medicine.

Dr. Czechowicz’s research laboratory focuses on studying hematopoietic stem cells and improving the utilization of these cells for the treatment of diverse blood and immune diseases. She has conducted pioneering work showing that hematopoietic stem cell depletion is a critical component to donor hematopoietic stem cell engraftment and multiple pre-clinical and clinical therapies are in development based upon her studies aimed at the elimination of chemotherapy and irradiation from transplant protocols. Furthermore, Dr. Czechowicz’s clinical interests are in bone marrow failure syndromes with a particular interest in the inherited cancer predisposition syndrome Fanconi Anemia and she has led several innovative cell and gene therapy trials attempting to improving outcomes for patients with this disease. Her laboratory is also studying bone marrow failure and hematopoietic stabilization in the context of these clinical trials and conducting pioneering new preclinical work in Fanconi Anemia mouse models. She was recently recognized for her contributions by the Fanconi Cancer Foundation with the prestigious David B. Frohnmayer Early Career Investigator Award. Dr. Czechowicz is also quite passionate about mentoring and training future generations of physicians and scientists and is very supportive of helping diverse trainees on various traditional and non-traditional career paths.

Dr Czechowicz will be presenting her talk entitled "Development and Application of Non-Genotoxic Conditioning to Enable Curative Treatment of Diverse Diseases"